SUBSCRIBE
SUBSCRIBE

Events

Drug Development
Nektar Therapeutics To Present At Jefferies Autumn 2015 Global Healthcare Conference In London
November 17, 2015
 · 
2 min read
Northern California Prepares for Talent Connect as Bay Area Life Science Companies Plan to Add Staff
Job Trends
Northern California Prepares for Talent Connect as Bay Area Life Science Companies Plan to Add Staff
October 23, 2015
 · 
3 min read
Pharm Country
One Stage: $700 Billion Of Pharma Firepower
October 20, 2015
 · 
1 min read
Pharm Country
Quantum Medical Imaging, LLC Installs A Q-Rad-Digital Radiographic System At Orthopedic Associates Of Dutchess County
August 25, 2015
 · 
2 min read
DIA2015: EXCLUSIVE: One-Size-Fits-All Model for Drug Development “Outdated,” Medidata Exec Tells BioSpace
Pharm Country
DIA2015 EXCLUSIVE: Clinical Data Remains the “Foundation” for Product Development, Medidata Solutions, Inc. Exec Says
June 19, 2015
 · 
4 min read
DIA2015: EXCLUSIVE: One-Size-Fits-All Model for Drug Development “Outdated,” Medidata Exec Tells BioSpace
Pharm Country
DIA2015: EXCLUSIVE: One-Size-Fits-All Model for Drug Development “Outdated,” Medidata Solutions, Inc. Exec Tells BioSpace
June 19, 2015
 · 
2 min read
DIA2015: EXCLUSIVE: One-Size-Fits-All Model for Drug Development “Outdated,” Medidata Exec Tells BioSpace
Pharm Country
DIA2015 EXCLUSIVE: Medical App Market Will Reach $26B By 2017, Is the “Future of Healthcare,” Exec Tells BioSpace
June 19, 2015
 · 
3 min read
BIO2015 EXCLUSIVE: Biosimilars Are the
Pharm Country
BIO2015 EXCLUSIVE: Brazil and Biotech Go Hand in Glove, MedImmune Exec Tells BioSpace
June 19, 2015
 · 
3 min read
BIO2015 EXCLUSIVE: Biosimilars Are the
Pharm Country
BIO2015 EXCLUSIVE: MedImmune Exec Says Key to Ending “Superbugs” Is Personalized Medicine
June 17, 2015
 · 
3 min read
BIO2015 EXCLUSIVE: Biosimilars Are the
Pharm Country
BIO2015 EXCLUSIVE: Ontario Open for Business As Biotech Booms, Says Government
June 17, 2015
 · 
4 min read
Load More
PRESS RELEASES
Press Releases
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
April 21, 2026
 · 
4 min read
Press Releases
Verismo Therapeutics Presents Preclinical Data at AACR 2026 for SynKIR™-310 KIR-CAR Indicating Superior Preclinical Activity in B Cell Malignancies and Early Clinical Efficacy
April 21, 2026
 · 
7 min read
Press Releases
Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform
April 21, 2026
 · 
8 min read
Press Releases
Forlong Biotechnology to Present Clinical Data from the First-in-human Study for FL115 (IL-15 Superagonist) in US Patients with Advanced Solid Tumors at 2026 ASCO Annual Meeting
April 21, 2026
 · 
2 min read
Press Releases
ImmunoScape Presents Data on Significant, Selective In-Vivo Expansion of Cell Therapy Product at AACR Annual Meeting
April 21, 2026
 · 
5 min read
Press Releases
Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting
April 21, 2026
 · 
3 min read
Press Releases
Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting
April 21, 2026
 · 
7 min read
Press Releases
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026
April 21, 2026
 · 
2 min read
Press Releases
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting
April 21, 2026
 · 
5 min read
Press Releases
Ambrosia Biosciences Announces Late-Breaking Poster Presentation at the American Diabetes Association’s (ADA) 86th Scientific Session
April 21, 2026
 · 
2 min read
Press Releases
IDEAYA Biosciences Announces Late-Breaking Abstract Oral Presentation at ASCO 2026 to Provide Complete Data from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in 1L HLA*A2-Negative Metastatic Uveal Melanoma
April 21, 2026
 · 
4 min read
Press Releases
Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting
April 21, 2026
 · 
2 min read
Press Releases
BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting
April 21, 2026
 · 
5 min read
Press Releases
ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026
April 21, 2026
 · 
4 min read
Press Releases
Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026
April 21, 2026
 · 
5 min read
Press Releases
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
April 21, 2026
 · 
4 min read
Press Releases
Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
April 21, 2026
 · 
4 min read
Press Releases
Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026
April 21, 2026
 · 
3 min read
Press Releases
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
April 21, 2026
 · 
4 min read
Press Releases
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
April 21, 2026
 · 
5 min read
Load More